Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 3/20 | 0.57 |
| ▸ | CTSC | P53634 | 2/20 | 0.53 |
| ▸ | MME | P08473 | 3/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.53 |
| ▸ | CPA1 | P15085 | 1/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | XIAP | P98170 | 1/20 | 0.53 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ECE1 | P42892 | 1/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3052110 | 1.00 | CTSD (0.57) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30050842 | 0.97 | CTSD (0.60) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL31462339 | 0.97 | CTSD (0.60) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL29720334 | 0.95 | CTSD (0.53) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30051265 | 0.95 | CTSD (0.53) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL3202596 | 0.95 | CTSD (0.64) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30050940 | 0.95 | CTSD (0.64) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL30051904 | 0.94 | MME (0.57) | CTSDMMEACECPA1ACE2 | |
| SCHEMBL30052924 | 0.92 | CTSD (0.64) | CTSDCTSCMMEACECPA1 | |
| SCHEMBL31590754 | 0.92 | MME (0.52) | CTSDCTSCMMEACECPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116087482-B | Biomarkers for severity typing of course of patients with 2019 novel coronavirus infection | 广州国家实验室 | 2023-07-11 | — | — | CN | claimed |
| CN-116087482-A | Biomarkers for novel patient progression severity typing for coronavirus infection | 广州国家实验室 | 2023-05-09 | — | — | CN | claimed |
| EP-3805756-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2021-04-14 | — | — | EP | claimed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | claimed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| US-20240230622-A9 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240133865-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-04-25 | — | — | US | disclosed |
| US-20240019417-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-01-18 | — | — | US | disclosed |
| CN-116087482-B | Biomarkers for severity typing of course of patients with 2019 novel coronavirus infection | 广州国家实验室 | 2023-07-11 | — | — | CN | disclosed |
| US-11674948-B2 | Methods and systems for determining autism spectrum disorder risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2023-06-13 | — | — | US | disclosed |
| CN-116087482-A | Biomarkers for novel patient progression severity typing for coronavirus infection | 广州国家实验室 | 2023-05-09 | — | — | CN | disclosed |
| EP-1424066-A1 | Dry compositions comprising hydrophobic stabilisers | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-02 | — | — | EP | disclosed |
| EP-1402913-A1 | DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2004-03-31 | — | — | EP | disclosed |
| US-20030138402-A1 | Dry compositions | OTSUKA PHARMACEUTICAL CO., LTD. | 2003-07-24 | — | — | US | disclosed |
| US-20030101995-A1 | Dry powder inhalation system for transpulmonary administration | OTSUKA PHARMACEUTICAL CO., LTD. | 2003-06-05 | — | — | US | disclosed |
| CN-1205643-A | dry composition | OTSUKA PHARMA CO LTD (JP) | 1999-01-20 | — | — | CN | disclosed |
| EP-0869816-A1 | DRY COMPOSITIONS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997023239-A1 | DRY COMPOSITIONS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-07-03 | — | — | WO | disclosed |